Sanofi SA vs Vanguard Total World Stock Index Fund ETF — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Vanguard Total World Stock Index Fund ETF trades at $156.25. The key difference: Sanofi SA pays a 5.5% dividend while Vanguard Total World Stock Index Fund ETF pays none, and Vanguard Total World Stock Index Fund ETF is trading nearer its 52-week high, Sanofi SA nearer its low. Which is the better fit depends on your goals.
| SNY | VT | |
|---|---|---|
Market Cap | $104.83B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $52.34 | $159.35 |
52-Week Low | $41.33 | $128.41 |
Enterprise Value | $121.32B | — |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →